Susquehanna International Group, LLP Kal Vista Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$10.35 - $12.49 $362,250 - $437,150	-35,000 Reduced 73.68%	12,500 $147,000
Q1 2024 May 07, 2024	SELL	$11.07 - $16.04 $2.66 Million - $3.86 Million	-240,700 Reduced 83.52%	47,500 $563,000
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $1.25 Million - $2.02 Million	164,900 Added 133.74%	288,200 $3.53 Million
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $820,714 - $1.04 Million	91,700 Added 290.19%	123,300 $1.19 Million
Q2 2023 Aug 11, 2023	BUY	$7.73 - $10.57 $244,268 - $334,012	31,600 New	31,600 $284,000
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $13,790 - $23,561	-1,400 Reduced 1.44%	96,100 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $484,704 - $896,940	59,400 Added 155.91%	97,500 $959,000
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $314,720 - $476,856	28,100 Added 281.0%	38,100 $562,000
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $595,428 - $852,252	-34,800 Reduced 77.68%	10,000 $175,000
Q2 2021 Aug 11, 2021	SELL	$23.12 - $29.91 $372,232 - $481,551	-16,100 Reduced 26.44%	44,800 $1.07 Million
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $193,908 - $561,924	13,200 Added 27.67%	60,900 $1.57 Million
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $614,376 - $928,719	47,700 New	47,700 $906,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.